Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anyone still monitoring this? Been getting hammered, seems like a good entry point.
TELADOC COULD BUY AMERICAN WELL
NO MORE
HOT STOCK PICK:
If you know your charts - take a look - a no brainer to head upwards and rake in dollars.
Strong Buy!
Breaking News Alert: Raised to BUY from Neutral - and Target Price announced at $15 by Guggenheim. To the roof she's heading.
Yikes didn’t last long. Terrible
Sold my shares from $21 to $41 in 3 months. I like Amwell long term but will look for a better re-entry. Good luck longs!
Yea looking strong
Beautiful at $33 today.
Today is $32.××.
Within two more weeks, Amal will be in $40 range.
OUTSTANDING!
The rest of stock markets are red , while amwl is green.
With amwl , we are not talking about penny. We are talking about $1 ,$2, $3, for upside.
If amwl can advance upside $7 every month then in one year, pps would be greater than $100.
Example
Tdoc did ipo back 2015 at around $30. Now tdoc is trading at $197
If amwl can advance upside $7 every month then in one year, pps would be greater than $100
I tracked the movements in one month..
Downsize minus upside = pps had advanced upside about $7 from 21.99 to $ 30.42
November 17, $21.99
Dec 2 (today), $26.xx
Upward movement will continue.
Great job
$40 with good news
Well then
Dow , Nasdaq and s & p 500 are red while amwl is green at 5.52 % higher than tdoc. So I think it is a good sign for good earning.
Amwl and tdoc are competitors to each other on main street , but on stock, they are allies.
When all tdoc or docrf are up high , amwl will be high also.
Earnings today.
Let’s see
Up up
a few dollars more
I expect it will reach above $35 by Tuesday next week.
I had been watching and preparing to buy at below $25. But it didn't drop below $25.
Anyway I am happy that bought at $25.35.
Today it's closed at above $29.
Not bad
Shorts?
Looking strong, liking the green bounce. Think we’re headed to $50+ or more by hear end
Think we may get a short squeeze here. Got some calls going....
Oct - Dec is a very busy telehealth month, and with the possibility of a second wave, the squeeze could be epic.
$AMWL
This is riding on TDOC coattails...nice ride!!
She got it
She wants $40
$35 and climbing.
Weeeeeee
Yep, looking better and better each day
Amwell Expands Partnership with Tyto Care to Extend Healthcare at Home
9:00 AM ET 9/30/20 | Dow Jones
Collaboration Will Allow Care Providers on Amwell Platform to Remotely Examine Patients Using Streaming Information from Tyto Devices, Extending the Scope of Care Rendered at Home.
BOSTON, Sept. 30, 2020 /PRNewswire/ -- Amwell(R) (NYSE: AMWL), a national telehealth leader, today announced it is expanding its partnership with Tyto Care, the healthcare industry's first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams. Together the companies will introduce exclusive integrations and newly designed workflows and tools to enhance the ability for providers using the Amwell platform to examine and diagnose patients virtually. Additionally, Amwell will become a reseller of Tyto Care's integrated devices.
By pairing the TytoHome handheld examination device -- which enables on-demand examinations of the heart, lungs, abdomen, skin, throat, ears, heart rate, and body temperature -- with Amwell's telehealth platform, providers can guide patients through virtual health examinations and together gain real-time insight into a patient's health data and status directly in the visit. For patients and providers, this will augment the virtual care experience and more broadly enrich the capabilities and overall satisfaction associated with healthcare organizations' virtual care applications. This enriched workflow will be available to thousands of Amwell hospitals, health systems, health plans and employer clients who collectively serve millions of patients.
"As COVID-19 wages on and more patients and providers adopt telehealth, it's critical that we accelerate the depth of care that can be provided in the home -- to keep patients and providers safe," said Roy Schoenberg, President and Co-CEO, Amwell. "Our latest integration with Tyto Care will allow providers to clinically come closer than ever before to patients during telehealth encounters, allowing them to see, interact, examine and deliver care in ways that growingly resemble in-person care."
"Our longstanding partnership with Amwell exemplifies our shared goal of providing deeply integrated telehealth solutions that put health in the hands of consumers, creating a more impactful and seamless healthcare experience for both patients and providers," said Dedi Gilad, CEO and Co-Founder, Tyto Care. "The integration with TytoHome will enable Amwell to offer more holistic care for patients, especially for urgent and primary care needs, as well as help to enable better adherence to treatment plans. We look forward to continuing our work together as we realize the full potential of clinic-quality, at-home care in this new era of telehealth."
One of those IPOs folks a year from now investors will be kicking themselves they didn’t buy for under $100 lol.
30s want to break looking good
Will be half of TDOC price in about 6 months... sooner if any lock downs happen this winter!
AMWL nice jump today after its ipo ~
Going looooooooooong
Looking good
Good buy, going long
Thinking this will gain some traction here in weeks/months to come
IPO has Google backing, took a position at $23.50, tight stop.
Telehealth IPO
American Well Corporation is a telehealth company enabling digital delivery of care for the healthcare sector. The Amwell Platform is a digital care delivery solution that equips its health system and health plan, including government, clients with the tools to enable new models of care for their patients and members. Its technology embeds with its clients' existing offerings and clinical workflows, spanning the continuum of care and enabling care delivery across a range of clinical, retail, school and home settings. The Amwell Platform consists of the home line, provider-to-patient telehealth interactions, typically in the home, and the hospital line, supporting provider-to-provider telehealth interactions, or provider-to-patient, typically in an inpatient or ambulatory setting. The Company offers a range of management software, clinical workflows, Carepoint hardware and system integrations to deliver care across various modalities, including video, phone and secure messaging.
Followers
|
2
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
46
|
Created
|
09/17/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |